It’s clear that short term punters were expecting a 100% intraday spike or so (ie 30-40c).
The reality is that for that to happen the US results needs to be out and positive and FDA paperwork submitted. I’d expect 40-60c around Christmas -if everything on track and positive- and after the approvals are granted who knows. There may be a strategic CR in Q4 after CE/FDA approvals as well.
Another 12 months and we will be starting to see the first revenues banked and recorded in the books.
RAP Price at posting:
23.3¢ Sentiment: Buy Disclosure: Held